Literature DB >> 32070652

The role of spinal inhibitory neuroreceptors in the antihyperalgesic effect of warm water immersion therapy.

Fernanda Madeira1, Rômulo Nolasco de Brito1, Aline A Emer1, Ana Paula Batisti1, Bruna Lenfers Turnes2, Afonso Shiguemi Inoue Salgado3, Francisco José Cidral-Filho1, Leidiane Mazzardo-Martins4, Daniel Fernandes Martins5.   

Abstract

OBJECTIVE: Warm water immersion therapy (WWIT) has been widely used in the treatment of various clinical conditions, with analgesic and anti-inflammatory effects. However, its mechanism of action has not been fully investigated. The present study analyzed the role of spinal inhibitory neuroreceptors in the antihyperalgesic effect of WWIT in an experimental model of inflammatory pain.
METHODS: Mice were injected with complete Freund's adjuvant (CFA; intraplantar [i.pl.]). Paw withdrawal frequency to mechanical stimuli (von Frey test) was used to determine: (1) the effect of intrathecal (i.t.) preadministration of naloxone (a non-selective opioid receptor antagonist; 5 µg/5 µl), (2); AM281 (a selective cannabinoid receptor type 1 [CB1] antagonist; 2 µg/5 µl), (3); and 1,3-dipropyl-8-cyclopentylxanthine (DPCPX; a selective adenosine A1 receptor antagonist; 10 nmol/5 µl), on the antihyperalgesic (pain-relieving) effect of WWIT against CFA-induced hyperalgesia.
RESULTS: Intrathecal naloxone, AM281, and DPCPX significantly prevented the antihyperalgesic effect of WWIT. This study suggests the involvement of spinal (central) receptors in the antihyperalgesic effect of WWIT in a model of inflammatory pain.
CONCLUSIONS: Taken together, these results suggest that opioid, CB1, and A1 spinal receptors might contribute to the pain-relieving effect of WWIT.
Copyright © 2020 Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Adenosine; Cannabinoid; Opioid; Physical therapy; Rehabilitation

Mesh:

Substances:

Year:  2020        PMID: 32070652      PMCID: PMC7817861          DOI: 10.1016/j.bjpt.2020.02.001

Source DB:  PubMed          Journal:  Braz J Phys Ther        ISSN: 1413-3555            Impact factor:   3.377


  28 in total

Review 1.  Caffeine and pain.

Authors:  Jana Sawynok
Journal:  Pain       Date:  2010-10-30       Impact factor: 6.961

2.  Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline.

Authors:  M I Sweeney; T D White; J Sawynok
Journal:  J Pharmacol Exp Ther       Date:  1987-11       Impact factor: 4.030

Review 3.  Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry.

Authors:  A I Basbaum; H L Fields
Journal:  Annu Rev Neurosci       Date:  1984       Impact factor: 12.449

Review 4.  Cannabinoid mechanisms of pain suppression.

Authors:  J M Walker; A G Hohmann
Journal:  Handb Exp Pharmacol       Date:  2005

Review 5.  Nonpharmacological treatments for musculoskeletal pain.

Authors:  A Wright; K A Sluka
Journal:  Clin J Pain       Date:  2001-03       Impact factor: 3.442

6.  High-Intensity Swimming Exercise Decreases Glutamate-Induced Nociception by Activation of G-Protein-Coupled Receptors Inhibiting Phosphorylated Protein Kinase A.

Authors:  Daniel F Martins; Aline Siteneski; Daniela D Ludtke; Daniela Dal-Secco; Adair R S Santos
Journal:  Mol Neurobiol       Date:  2016-09-13       Impact factor: 5.590

Review 7.  Adenosine in the spinal cord and periphery: release and regulation of pain.

Authors:  Jana Sawynok; Xue Jun Liu
Journal:  Prog Neurobiol       Date:  2003-04       Impact factor: 11.685

8.  Analgesia mediated by a direct spinal action of narcotics.

Authors:  T L Yaksh; T A Rudy
Journal:  Science       Date:  1976-06-25       Impact factor: 47.728

9.  Ankle joint mobilization affects postoperative pain through peripheral and central adenosine A1 receptors.

Authors:  Daniel F Martins; Leidiane Mazzardo-Martins; Francisco J Cidral-Filho; Juliana Stramosk; Adair R S Santos
Journal:  Phys Ther       Date:  2012-10-19

10.  Electroacupuncture Attenuates CFA-induced Inflammatory Pain by suppressing Nav1.8 through S100B, TRPV1, Opioid, and Adenosine Pathways in Mice.

Authors:  Hsien-Yin Liao; Ching-Liang Hsieh; Chun-Ping Huang; Yi-Wen Lin
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.